Carcinoid patients are diagnosed biochemically on the basis of increased urinary excretion of 5-hydroxyindoleacetic acid (5-HIAA); urinary and platelet serotonin concentrations are considered to provide complementary information. Using established HPLC methods with ftuorometric detection, we evaluated the clinicalusefulness of measurements of urinary 5-HIAA and urinary, plasma, and platelet serotonin in 30 consecutive patients with histologically proven carcinoid tumors of fore-, mid-, and hindgut origin before treatment. Ten patients showed no signs of serotonin overproduction; 14 had increased concentrations of urinary 5-HIAA and platelet serotonin; and platelet serotonin, but not urinary 5-HIAA, was increased in 6. None had increased urinary 5-HIAA excretion without an increase in platelet serotonin content. In cases with high rates of tumor serotonin secretion, platelet serotonin reached a maximum and did not correlate with serotonin secretion rate, whereas urinary 5-HIAA was correlated. Increased platelet serotonin was correlated with increased plasma serotonin and with occurrence of carcinoid syndrome. Increased urinary serotonin, allegedly caused by increases in circulating 5-hydroxytryptophan, almost invariably coincided with increased platelet serotonin, but not necessarily with above-normal urinary 5-HIAA excretion. From these results and long-term monitoring of three patients during treatment, we conclude that platelet serotonin is more sensitive than urinary 5-HIAA for detecting carcinoids that secrete only small amounts of serotonin. -17%, respectively). Depending on the origin and size of the primary lesion, distant metastases (usually to liver) can occur. The predilection to deliver metastases amounts to 14-50%, 2-60%, and 3% in fore-, mid-, and hindgut, respectively (5).
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The occurrence and severity of the carcinoid syndrome, the endocrine manifestation of enterochromaflln cell neoplasm (6) , are directly related to tumor bulk in an area that drains into the systemic circulation (1). It is (17) . Platelet serotonin content, expressed in nanomoles of serotonin per 10#{176} platelets, was calculated by dividing the concentration of serotonin in platelet-rich plasma by the concentration of platelets in the plasma. Here we refer to the results of these calculations as "apparent platelet serotonin content," because the serotonin in platelet-rich plasma was not necessarily confined to platelets in all cases (see Discussion) .
Urinary 5-HIAA concentrations were determined in ether extracts by HPLC with fluorometric detection, essentially as described by Rosano We calculated 95% confidence intervals by nonparainetric analyses (19) . To estimate the 5 
Results
In the group of 26 healthy adults, the distributions of urinary 5-HIAA and serotomn excretion amounts and plasma serotonin concentration appeared to be skewed upward (nongaussian), whereas apparent platelet serotonin was skewed toward lower values. Reference values were therefore expressed as medians and 95% nonparametric confidence intervals.
For healthy adults these were urinary 5-HIAA, 1.6 and 0.8-3.8 mmollmol creatinine; urinary serotonin, 36 and 25-66 imolJmol creatinine; apparent platelet serotonin content, 4.4 and 2.9-5.4 nmolliO#{176} platelets; and plasma serotonin concentration, not detectable (<0.5 nmol/L) and <0.5-33.3 nmolJL plasma. Table 1 lists the pretherapeutic amounts of 5-HIAA and serotonin in various compartments, the site of the primary tumor, the location of any metastases, and associated carcinoid syndrome symptoms. In the 11 patients with foregut carcinoids, five had borderline to moderately increased apparent platelet serotonin contents, but only one had above-normal excretion of urinary 5-HIAA. All 14 patients with midgut carcinoid tumors showed markedly increased apparent platelet serotonin contents; in 13, urinary 5-HLAA excretions were grossly increased. In the five patients with hindgut carcinoid, one patient showed increased apparent platelet serotonin content; none had above-normal urinary 5-HIAA excretion. The urinary excretion of serotonin was above the upper limit of the conffdence interval in 2 of 7, 10 of 13, and 2 of 5 patients with tumors of fore-, mid-, and hindgut origin, respectively. (Table 1 ) ranged from 0.011 to 12 500 and 0.006 to 36400 nmol/g wet tissue, respectively. Primary foregut (n = 4; all lung; 0.011-98.3 ninol/g wet tissue) and hindgut (n = 1; rectum; 37.5 nmol/g wet tissue) carcinoids had lower serotomn contents than midgut carcinoids (n = 2; both ileal; 370 and 12 500 nmollg wet tissue). In patients with midgut carcinoids this coincided with higher apparent platelet serotonin content, higher urinary 5-HIAA and serotonin values, higher serotonin content of metastases (n = 2; both liver; 28 400-36 400 nmol/g wet tissue), and the occurrence of carcinoid syndrome symptoms. Figure   2 shows long-term monitoring of apparent platelet serotonin contents and urinary 5-HIAA excretion amounts for patients 14 and 21, both having liver involvement by a carcinoid of midgut origin, and for patient 4, who had a primary foregut (epiglottis) carcinoid and developing skin metastases (see Table 1 Patient 4 initially had a marginally increased platelet serotonin content and normal values for urinary 5-HIAA and serotonin excretion. During the course of his disease, multiple skin metastases appeared. This had no effect on urinary 5-HIAA excretion values, but platelet serotonin increased by >300%. Chemotherapy, although having no significant effect on the clinical status, caused a decrease in platelet serotonin content.
From the 27 patients studied longitudinally, we analyzed an average of 18 samples (range for platelet serotomn, 13 samples (range 2-74) for urinary 5-HIAA, and 9 samples (range 1-29) for urinary serotonin. Apart from the effects of surgical or systemic treatment and strongly progressive disease, we observed no major changes in the ratio between platelet serotonin concentration and urinary 5-HIAA excretion, thus confirming the previous finding that platelet serotonin provided greater pretherapeutic sensitivity than did urinary 5-HIAA (data not shown). Table 1 shows that, for 30 consecutive patients with carcinoid tumors referred to our hospital, apparent platelet serotonin content is a more sensitive marker for the diagnosis of carcinoid tumors of various origins than is the urinary 5-HIAA excretion value. This was especially true for patients with foregut carcinoids, who secrete only small amounts of serotonin. Thus, for the diagnosis of these patients, who often present without the symptoms of the carcinoid syndrome, measurement of platelet serotonin can be a valuable diagnostic aid. The courses of apparent platelet serotonin content and urinary 5 -HIAA values in one of the longitudinally monitored patients (Figure 2A) suggest that increasing serotonin production by a proliferating carcinoid tumor becomes at first noticeable from the apparent platelet serotonin content, whereas the urinary 5-HIAA excretion value exceeds the upper limit of the reference range at a later stage. This was also noticeable in three other patients, for whom longitudinal data were not shown.
DIscussion
Direct measurement of serotonin in platelet-rich plasma by HPLC with fluorometric detection, plus expression of results per number of platelets, yielded a reference range of 2.9-5.4 nmolJlO9 platelets, which compares favorably with data from others using similar methods (25, 26) . Although the median age of the control subjects (30 years) differs from that of the carcinoid patient group (59.5 years), it is reasonable to assume that the upper values of the analytes established for the control group are valid for the evaluation of the patient group. Platelet serotonin content is known to be age dependent, being about 30% lower in elderly subjects than in adults and children (27) . For urinary 5-HIAA excretion no age dependency has been reported, whereas urinary creatinine excretion decreases with age (28) . We therefore conclude that the difference in age between the control group and the carcinoid group has not biased our results.
Measurements of serotonin in urine, plasma, and platelets can give additional information for the diagnosis of patients with carcinoid tumors (12,29) . On the basis of one case with hyperserotonemia and normal (Figure 3 ). These data show that an increasing apparent platelet serotonin content measured in blood sampled from the cubital vein is accompanied by an increase in the concentration of serotomn in plateletpoor plasma. Crawford (16) , who studied in vivo and in vitro uptake of serotonin by normal and "carcinoid" platelets, found that, above -20 nmolJlO#{176} platelets, platelet and plasma serotonin contents exhibit a linear relationship. At greater values he suggested that the platelet serotonin uptake mechanism involves passive diffusion, as opposed to an active serotonin uptake mechanism at normal serotonin secretion rates. Thus, this value probably reflects a serotonin secretion rate that, on the average, equals the capacity of the whole body platelet pool to accumulate the released serotomn without giving rise to significant plasma serotonin values. Thus, for patients with serotonin-producing carcinoids who have apparent platelet serotonin values of at least 20 nmoIllO#{176} platelets, it is incorrect to ascribe all serotonin in platelet-rich plasma to the platelets for calculating the real platelet serotonin content. We therefore refer to this measurement as the "apparent platelet serotonin content." With increasing rates of serotonin secretion, apparent platelet serotomn contents finally plateau at about 45 nmol/109 platelets. At this value, apparent platelet serotonin content does not relate to the serotonin secretion rate at all, whereas urinary 5-HIAA excretion still does.
Theoretically, platelet serotonin content could conceivably give more relevant information for the diagnosis of carcinoid tumors that secrete small amounts of serotonin than does the urinary 5-HIAA excretion value. Using a two-compartment system, we calculated that under normal conditions platelet turnover in the platelet serotonin pool produces 1.2 .omol of 5 whereas the reference range of urinary 5-FIIAA is wider. The latter is at least partly caused by dietary influences, e.g., ingestion of serotoninrich foods such as bananas, pineapples, and walnuts (32) . Serotonin catabolism (within the tumor or by other organs) before reaching platelets for uptake will decrease the above-calculated sensitivity of platelet serotonin and increase that of urinary 5-HIAA. In the present group of patients, however, we did not encounter cases that could be diagnosed on the basis of increased urinary 5-HIAA excretion only.
All but 2 of 14 patients exhibiting carcinoid syndrome (Table 1) had apparent platelet serotonin contents >20 nmolJlO9 platelets, which suggests that, when the tumor serotonin secretion rate exceeds the platelet uptake capacity, the resulting accumulation of serotonin in plasma can lead to some of the symptoms of the carcinoid syndrome. Serotonin overproduction has especially been implicated in the etiology of diarrhea and, in long-standing disease, valvular heart disease (1). The role of serotonin in flushing is disputed, because other mediators may also be involved (5, 33, 34). In our patient group, 12 of 14 patients with serotonin production rates beyond the platelet uptake capacity exhibited flushing.
Carcinoid tumors arising from the foregut may possess low activities of aromatic L-amino acid decarboxylase However, the conversion of 5-HTP to serotonin by other tissues may contribute to the platelet serotonin pool, as suggested by experiments in which labeled 5-HIP was infused and labeled serotonin was recovered from platelets (22) . From the 30 patients in our group, 14 exhibited increased urinary serotonin values ( Table 1 ) that may predominantly have originated from circulating 5-HIP. All but one (no. 27) had increased apparent platelet serotonin content, whereas three exhibited normal urinary 5-HIAA excretion. We therefore conclude that, in general, platelet serotonin content is as informative as measurement of circulating or urinary 5-HTP. The low sensitivity of urinary serotonin in patients with foregut carcinoids does not support consistent excretion of 5-HTP by these tumors.
